SSA
TECX

Schonfeld Strategic Advisors’s Tectonic Therapeutic TECX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,109
Closed -$816K – 2771
2025
Q4 		$816K Buy
+39,109
New +$727K ﹤0.01% 1207
2025
Q2 		– Sell
-14,296
Closed -$253K – 2639
2025
Q1 		$253K Sell
14,296
-3,049
-18% -$99.4K ﹤0.01% 1858
2024
Q4 		$801K Buy
17,345
+2,345
+16% +$99.2K ﹤0.01% 1216
2024
Q3 		$455K Buy
+15,000
New +$274K ﹤0.01% 1476
2022
Q2 		– Sell
-833
Closed -$14K – 3084
2022
Q1 		$14K Buy
+833
New +$17.2K ﹤0.01% 2409
2021
Q1 		– Sell
-1,743
Closed -$291K – 2167
2020
Q4 		$291K Buy
1,743
+75
+4% +$13.3K ﹤0.01% 1216
2020
Q3 		$261K Sell
1,668
-620
-27% -$125K 0.01% 1137
2020
Q2 		$479K Buy
+2,288
New +$471K 0.01% 818
2019
Q4 		– Sell
-10,692
Closed -$1.81M – 1520
2019
Q3 		$1.81M Buy
+10,692
New +$2.42M 0.05% 329

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Schonfeld Strategic Advisors's TECX Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 39,109 shares — an estimated $816K sold.

Schonfeld Strategic Advisors first reported a position in TECX in Q3 2019 and held it in 9 quarters. The position peaked at $1.81M in Q3 2019. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 39,109 Tectonic Therapeutic shares in Q1 2026, an estimated $816K.
  • Schonfeld Strategic Advisors first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's Tectonic Therapeutic position peaked at $1.81M in Q3 2019.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.